Bringing the fundamentals into focus…
Back to Evotec SE
How Evotec SE stacks up
EVO · against 468 other Healthcare companies of similar size
Profitability
30/ 100
Below the middle of the pack.
Ranked #317 of 469 · scores higher than 31% of peers
Bars: peers in each 10-point band of the profitability score65 peers with a profitability score of 30–39, including EVO · Click a bar to see the companies
Why profitability scores 30?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 73% of peers. Operating margin: -7.1% vs peer median 7.1%
- a lower return on assets: weaker than 72% of peers. Return on assets: -6.0% vs peer median 1.7%
- a lower return on invested capital: weaker than 72% of peers. Return on invested capital: -6.6% vs peer median 4.7%
Metric by metric
Position: dot = EVO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | EVO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 443 reported | -6.6% | 2.2% | 30% | 33% | |
| Operating marginHigher is better · 441 reported | -7.1% | 4.8% | 30% | 33% | |
| Return on assetsHigher is better · 464 reported | -6.0% | 0.9% | 27% | 33% | |
| Return on equityHigher is better · 443 reported | -26.1% | 1.3% | 23% | Context only | |
| Gross marginHigher is better · 486 reported | 8.5% | 40.4% | 16% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around EVO| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 914M USD | 99 | 81 | |
| 1 | 609M USD | 99 | 91 | |
| 317 | 6.8B CNY (≈$946M) | 30 | 21 | |
| 317 | 1.4B MYR (≈$309M) | 30 | 31 | |
| 317 | 2.4B HKD (≈$310M) | 30 | 52 | |
| 317 | 327M USD | 30 | 40 | |
| 317 | 551M USD | 30 | 27 | |
| 317 | 820M USD | 30 | 41 | |
| 317 | 354M USD | 30 | 41 | |
| 327 | 5.2B CNY (≈$723M) | 29 | 9 | |
| 327 | 5.1B CNY (≈$709M) | 29 | 12 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score